Effect of compound EXP-2528 on angiotensin II-induced E-selectin and VCAM-1 expression in rat brain microvascular endothelial cells in vitro / 药学学报
Yao Xue Xue Bao
; (12): 822-827, 2007.
Article
em En
| WPRIM
| ID: wpr-268572
Biblioteca responsável:
WPRO
ABSTRACT
The aim of this study is to investigate the effect and mechanism of angiotensin (Ang) II on E-selectin and vascular cell adhesion molecule-1 (VCAM-1) expression in rat brain microvascular endothelial cells (BMEC) and evaluate the effect of compound EXP-2528, a novel Ang II type 1 (AT1) receptor antagonist. The experiment was performed in cultured BMEC of rat. The mRNA and protein expression of E-selectin and VCAM-1 in BMEC was analyzed by RT-PCR and Western blotting, respectively. The results showed that the mRNA and protein expression of E-selectin and VCAM-1 in BMEC were significantly upregulated by 4 h or 18 h exposure to 1 x 10(-7) mol x L(-1) Ang II. These effects were abolished by pretreatment with the selective AT1 receptor antagonists losartan and compound EXP-2528, but not with the AT2 selective antagonist PD123319. Combining losartan with PD123319 also significantly inhibited Ang II-induced E-selectin and VCAM-1 expression in BMEC, but there was no significant difference compared with losartan group. These findings indicated that Ang II upregulated E-selectin and VCAM-1 in BMEC by activating AT1 receptor and then involved in the development of cerebrovascular disease.
Texto completo:
1
Índice:
WPRIM
Assunto principal:
Farmacologia
/
Encéfalo
/
RNA Mensageiro
/
Angiotensina II
/
Células Cultivadas
/
Molécula 1 de Adesão de Célula Vascular
/
Selectina E
/
Losartan
/
Biologia Celular
/
Células Endoteliais
Limite:
Animals
Idioma:
En
Revista:
Yao Xue Xue Bao
Ano de publicação:
2007
Tipo de documento:
Article